drugset / Trial / NCT02933229

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

NCT02933229 ↗

Phase 4 Not yet recruiting 300 enrolled Shandong University
NaSingle-groupOpen-labelPrevention

Summary

Helicobacter pylori (H. pylori) infection, affecting an estimated 50% of the global population, is a main cause of chronic gastritis, peptic ulcers and gastric cancer. By causing progressive damage to the stomach and may eventually result in gastric atrophy, H. pylori infection has been demonstrated to be responsible for more than 95% of gastric malignancies

Timeline

Start
2016-10
Primary completion
2031-10
Completion
2031-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified — —
Subject Clarithromycin Small molecule — —
Subject Esomeprazole Small molecule — —
Subject colloidal bismuth pectin Unknown — —